Time to relapse after tildrakizumab withdrawal in patients...

  • Main
  • 2020 / 09
  • Time to relapse after tildrakizumab withdrawal in patients...

Time to relapse after tildrakizumab withdrawal in patients with moderate‐to‐severe psoriasis who were responders at week 28: post‐hoc analysis through 64 weeks from reSURFACE 1 trial

Warren, R.B., Carrascosa, J.M., Fumero, E., Schoenenberger, A., Lebwohl, M.G., Szepietowski, J.C., Reich, K.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Journal of the European Academy of Dermatology and Venereology
DOI:
10.1111/jdv.16964
Date:
September, 2020
File:
PDF, 1.01 MB
2020
Conversion to is in progress
Conversion to is failed